Contraception

Inclusion Criteria

- Female with age range 21 to 44 years
 - Subjects who are seeking permanent contraception
 - Subjects with body weight within range of 40 – 136 kilograms (90-300 pounds)
 - Subjects willing to accept the risk of pregnancy occurring while relying solely on the ESS505 as contraception
 - Subjects for whom medical history and physical examination indicates bilateral viable and patent fallopian tubes
 - Subjects who are able to comply with the protocol required follow-up visits (e.g., 3 month clinic visit, and the 12-month telephone interview)
 - Subjects who provide written informed consent prior to enrolment
 - Subjects who have sufficient mental capability to provide clinically relevant and reliable feedback regarding her experience wearing the device
 - Subjects agrees that her anonymised personal data will be made available to Study sponsor, requisite regional and international regulatory bodies
 - Subjects for whom there are no contraindications for use as described in the ESS505 Instructions for Use (IFU)

Exclusion Criteria

- Subjects with known proximal tubal occlusion in either fallopian tube
 - Subjects who have undergone fallopian tube sterilization procedure
 - Subjects diagnosed with unicornuate uterus
 - Subjects diagnosed with endometrial or myometrial pathology which may prevent fallopian tube ostia assessment
 - Subjects scheduled to undergo concomitant intrauterine procedures at the time of ESS505 placement; IUD removal is not considered a concomitant procedure
 - Subjects suspected of being or confirmed pregnant
 - Subjects post-partum or has undergone pregnancy termination ≤6 weeks of scheduled ESS505 placement
 - Subjects diagnosed with active upper or lower pelvic infection
 - Subjects for whom there are one or more contraindications for use as described in the ESS505 IFU
 - Subjects have positive pre-procedure pregnancy test